BAX
Baxter International Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+30/100
Last price
24.29
▲ 0.07 (0.29%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
24.27
Prev close
24.22
Day high
24.42
Day low
23.92
Volume
6.52M
Market cap
$12.59B
P/E (TTM)
—
52W range
15.73 – 30.00
Day trading desk
Gap from prior close
+0.21%
Prior close 24.22
VWAP
24.31
-0.07% from price
Relative volume
1.97×
Unusually busy
Session range
2.11%
23.92 – 24.42
Position in range
74%
Near session high
ATR (14D)
0.65
2.69% of price
Prior day high
24.29
PDH
Prior day low
23.24
PDL
Bid / ask spread
—
Quote not published
Session volume
13.08M
Avg 6.63M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.75%
+1.8%
1M
-5.69%
-6.8%
3M
+10.83%
+6.3%
6M
+46.57%
+28.4%
YTD
+27.47%
+13.2%
1Y
+2.10%
-14.3%
3Y
-35.45%
-117.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BAX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.73M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 1, 26 | ZIELINSKI ANITA A. Chief Financial Officer |
STOCK | 13.43K | $0 | Direct |
| May 5, 26 | SHAFER DAVID BRENT Chairman of the Board |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | MCDONNELL MICHAEL R Director |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | WILKES DAVID S. M.D. Director |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | AMPOFO WILLIAM A. II Director |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | WENDELL AMY MCBRIDE Director |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | MORRISON PATRICIA B Director |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | CRAIG JEFFREY A Director |
STOCK | 12.84K | $0 | Direct |
| May 5, 26 | SCHLICHTING NANCY M Director |
STOCK | 12.84K | $0 | Direct |
| Feb 27, 26 | ZIELINSKI ANITA A. Officer |
STOCK | 30.86K | $0 | Direct |
| Feb 27, 26 | ROSENBLOOM DAVID S General Counsel |
STOCK | 26.71K | $0 | Direct |
| Feb 27, 26 | HIDER ANDREW P Chief Executive Officer |
STOCK | 201.80K | $0 | Direct |
| Feb 27, 26 | CARLISLE CYNTHIA Officer |
STOCK | 29.68K | $0 | Direct |
| Feb 27, 26 | SORIANO MARIA CECILIA Officer |
STOCK | 23.74K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BORZI JAMES W |
Officer | 73.13K | Stock Award(Grant) |
GRADE JOEL T. |
Chief Financial Officer | 279.83K | Stock Award(Grant) |
HIDER ANDREW P |
Chief Executive Officer | 572.24K | Stock Award(Grant) |
KNIGHT HEATHER |
Chief Operating Officer | 177.36K | Stock Award(Grant) |
MASON JEANNE K |
Officer | 199.66K | Stock Award(Grant) |
RASUL REAZUR |
Officer | 139.85K | Stock Award(Grant) |
ROSENBLOOM DAVID S |
General Counsel | 144.84K | Stock Award(Grant) |
SHAFER DAVID BRENT |
Chairman of the Board | 72.80K | Stock Award(Grant) |
SONIG ALOK |
Officer | 130.30K | Stock Award(Grant) |
SORIANO MARIA CECILIA |
Officer | 77.89K | Stock Award(Grant) |
Fundamentals
Market cap$12.59B
Enterprise value$20.08B
Revenue (TTM)$11.47B
Gross profit$3.91B
EBITDA$1.88B
Net income$-968.00M
EPS (TTM)$-1.89
Free cash flow$1.00B
Total cash$2.15B
Total debt$9.67B
Book value / share$12.00
Shares outstanding517.00M
Float514.41M
Short % of float7.09%
Dividend yield0.16%
Beta (5Y)0.65
Valuation & profitability ratios
Trailing P/E—
Forward P/E11.94
PEG ratio36.68
Price / sales—
Price / book2.03
EV / revenue1.75
EV / EBITDA10.66
Gross margin34.10%
Operating margin14.43%
Profit margin-9.27%
Return on equity-14.37%
Return on assets2.85%
Debt / equity156.45
Current ratio1.95
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $11.24B | $10.64B | $10.36B | $10.06B | +5.7% |
| Operating revenue | $11.24B | $10.64B | $10.36B | $10.06B | +5.7% |
| Cost of revenue | $7.87B | $6.65B | $6.21B | $6.51B | +18.2% |
| Gross profit | $3.38B | $3.98B | $4.15B | $3.55B | -15.2% |
| Research & development | $518.00M | $590.00M | $518.00M | $450.00M | -12.2% |
| Selling, general & admin | $2.89B | $2.97B | $2.95B | $3.10B | -2.6% |
| Total operating expense | $3.20B | $3.54B | $3.44B | $3.58B | -9.7% |
| Operating income | $177.00M | $439.00M | $707.00M | -$33.00M | -59.7% |
| Net interest income | -$238.00M | -$341.00M | -$439.00M | -$394.00M | +30.2% |
| Pre-tax income | -$505.00M | -$289.00M | $242.00M | -$3.25B | -74.7% |
| Tax provision | $395.00M | $37.00M | $61.00M | -$135.00M | +967.6% |
| Net income | -$957.00M | -$649.00M | $2.66B | -$2.43B | -47.5% |
| Net income to common | -$957.00M | -$649.00M | $2.66B | -$2.43B | -47.5% |
| Basic EPS | -1.87 | -1.27 | 5.25 | -4.83 | -47.2% |
| Diluted EPS | -1.87 | -1.27 | 5.25 | -4.83 | -47.2% |
| EBIT | -$215.00M | $119.00M | $750.00M | -$2.83B | -280.7% |
| EBITDA | $766.00M | $1.12B | $1.73B | -$1.76B | -31.4% |
| Basic shares | 513.00M | 510.00M | 506.00M | 504.00M | +0.6% |
| Diluted shares | 513.00M | 510.00M | 506.00M | 504.00M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.97B | $1.76B | $3.08B | $1.72B | +11.5% |
| Cash & short-term investments | $1.97B | $1.76B | $3.08B | $1.72B | +11.5% |
| Accounts receivable | $1.86B | $1.68B | $1.72B | $2.57B | +10.8% |
| Inventory | $2.23B | $2.05B | $1.92B | $2.68B | +9.1% |
| Total current assets | $6.87B | $8.85B | $9.60B | $8.01B | -22.4% |
| Property, plant & equipment | $3.19B | $3.18B | $3.21B | $5.24B | +0.3% |
| Goodwill & intangibles | $9.30B | $10.50B | $11.71B | $13.24B | -11.4% |
| Total assets | $20.05B | $25.78B | $28.28B | $28.29B | -22.2% |
| Total current liabilities | $2.97B | $6.51B | $6.50B | $4.75B | -54.4% |
| Current debt | $3.00M | $2.75B | $2.67B | $1.40B | -99.9% |
| Long-term debt | $9.47B | $10.37B | $11.09B | $15.23B | -8.7% |
| Total debt | $9.78B | $13.45B | $14.11B | $17.20B | -27.3% |
| Total liabilities | $13.95B | $18.76B | $19.81B | $22.39B | -25.6% |
| Retained earnings | $13.71B | $14.93B | $16.11B | $14.05B | -8.2% |
| Shareholder equity | $6.13B | $6.96B | $8.40B | $5.83B | -12.0% |
| Working capital | $3.90B | $2.34B | $3.10B | $3.27B | +66.6% |
| Net tangible assets | -$3.17B | -$3.53B | -$3.31B | -$7.41B | +10.3% |
| Shares issued | 683.49M | 683.49M | 683.49M | 683.49M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$900.00M | -$326.00M | $181.00M | -$3.11B | — | -176.1% |
| Depreciation & amortisation | $981.00M | $997.00M | $984.00M | $1.07B | — | -1.6% |
| Stock-based compensation | $117.00M | $114.00M | $115.00M | $140.00M | — | +2.6% |
| Change in working capital | -$108.00M | -$236.00M | $161.00M | -$606.00M | — | +54.2% |
| Operating cash flow | $845.00M | $1.02B | $1.73B | $1.21B | — | -17.1% |
| Capital expenditure | -$522.00M | -$460.00M | -$436.00M | -$635.00M | — | -13.5% |
| Investing cash flow | $2.84B | -$626.00M | $3.21B | -$931.00M | — | +553.8% |
| Share buybacks | — | $0 | $0 | -$32.00M | -$600.00M | — |
| Dividends paid | -$348.00M | -$590.00M | -$586.00M | -$573.00M | — | +41.0% |
| Financing cash flow | -$4.22B | -$1.08B | -$3.49B | -$1.44B | — | -290.0% |
| Free cash flow | $323.00M | $559.00M | $1.29B | $576.00M | — | -42.2% |
| End cash position | $1.97B | $2.41B | $3.20B | $1.72B | — | -18.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.96B | $2.70B | $2.97B | $2.83B | $2.81B | +9.6% |
| Operating revenue | $2.96B | $2.70B | $2.97B | $2.83B | $2.81B | +9.6% |
| Cost of revenue | $1.93B | $1.81B | $2.40B | $1.89B | $1.82B | +6.5% |
| Gross profit | $1.03B | $891.00M | $577.00M | $950.00M | $991.00M | +15.8% |
| Research & development | $129.00M | $139.00M | $126.00M | $118.00M | $134.00M | -7.2% |
| Selling, general & admin | $735.00M | $728.00M | $761.00M | $708.00M | $718.00M | +1.0% |
| Total operating expense | $815.00M | $825.00M | $821.00M | $778.00M | $800.00M | -1.2% |
| Operating income | $217.00M | $66.00M | -$244.00M | $172.00M | $191.00M | +228.8% |
| Net interest income | -$64.00M | -$66.00M | -$58.00M | -$58.00M | -$58.00M | +3.0% |
| Pre-tax income | $158.00M | -$6.00M | -$756.00M | $121.00M | $133.00M | +2,733.3% |
| Tax provision | $23.00M | $11.00M | $279.00M | $172.00M | $11.00M | +109.1% |
| Net income | $126.00M | -$15.00M | -$1.13B | -$46.00M | $91.00M | +940.0% |
| Net income to common | $126.00M | -$15.00M | -$1.13B | -$46.00M | $91.00M | +940.0% |
| Basic EPS | 0.24 | -0.03 | -2.19 | -0.09 | 0.18 | +900.0% |
| Diluted EPS | 0.24 | -0.03 | -2.19 | -0.09 | 0.18 | +900.0% |
| EBIT | $235.00M | $72.00M | -$687.00M | $189.00M | $205.00M | +226.4% |
| EBITDA | $474.00M | $309.00M | -$447.00M | $426.00M | $462.00M | +53.4% |
| Basic shares | 517.00M | 515.00M | 514.00M | 514.00M | 513.00M | +0.4% |
| Diluted shares | 518.00M | 515.00M | 514.00M | 514.00M | 514.00M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.15B | $2.02B | $1.97B | $1.73B | $1.69B | +6.6% |
| Cash & short-term investments | $2.15B | $2.02B | $1.97B | $1.73B | $1.69B | +6.6% |
| Accounts receivable | $1.86B | $1.70B | $1.86B | $1.78B | $1.77B | +9.3% |
| Inventory | $2.26B | $2.32B | $2.23B | $2.46B | $2.38B | -2.5% |
| Total current assets | $6.99B | $6.85B | $6.87B | $6.93B | $6.75B | +2.1% |
| Property, plant & equipment | $3.17B | $3.19B | $3.19B | $3.08B | $3.09B | -0.5% |
| Goodwill & intangibles | $8.96B | $9.12B | $9.30B | $10.21B | $10.35B | -1.7% |
| Total assets | $19.79B | $19.85B | $20.05B | $21.07B | $21.05B | -0.3% |
| Total current liabilities | $3.59B | $3.69B | $2.97B | $3.77B | $2.94B | -2.8% |
| Current debt | $844.00M | $842.00M | $3.00M | $755.00M | $8.00M | +0.2% |
| Long-term debt | $8.62B | $8.62B | $9.47B | $8.75B | $9.49B | -0.1% |
| Total debt | $9.67B | $9.69B | $9.78B | $9.71B | $9.72B | -0.2% |
| Total liabilities | $13.61B | $13.83B | $13.95B | $13.85B | $13.75B | -1.6% |
| Retained earnings | $13.81B | $13.69B | $13.71B | $14.84B | $14.97B | +0.9% |
| Shareholder equity | $6.21B | $6.04B | $6.13B | $7.24B | $7.32B | +2.7% |
| Working capital | $3.40B | $3.15B | $3.90B | $3.16B | $3.81B | +7.7% |
| Net tangible assets | -$2.75B | -$3.07B | -$3.17B | -$2.96B | -$3.02B | +10.4% |
| Shares issued | 517.00M | 683.49M | 683.49M | 683.49M | 683.49M | -24.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $135.00M | -$17.00M | -$1.03B | -$51.00M | $122.00M | +894.1% |
| Depreciation & amortisation | $239.00M | $237.00M | $240.00M | $237.00M | $257.00M | +0.8% |
| Stock-based compensation | $33.00M | $10.00M | $37.00M | $35.00M | $35.00M | +230.0% |
| Change in working capital | -$81.00M | -$55.00M | $400.00M | -$28.00M | -$182.00M | -47.3% |
| Operating cash flow | $285.00M | $213.00M | $584.00M | $237.00M | $217.00M | +33.8% |
| Capital expenditure | -$119.00M | -$137.00M | -$140.00M | -$111.00M | -$149.00M | +13.1% |
| Investing cash flow | -$117.00M | -$133.00M | -$198.00M | -$111.00M | -$115.00M | +12.0% |
| Dividends paid | -$5.00M | -$5.00M | -$87.00M | -$87.00M | -$87.00M | 0.0% |
| Financing cash flow | -$31.00M | -$11.00M | -$147.00M | -$81.00M | -$762.00M | -181.8% |
| Free cash flow | $166.00M | $76.00M | $444.00M | $126.00M | $68.00M | +118.4% |
| End cash position | $2.16B | $2.02B | $1.97B | $1.73B | $1.69B | +6.8% |
Options analytics
Put / call volume
0.07
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
15.00
-38.4% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
1.39K
Contracts, this expiry
Put volume
98
Contracts, this expiry
Heaviest call OI
15.00
0 contracts
Heaviest put OI
15.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.37 | 0.56 | +52.5% |
| Mar 2026 | 0.31 | 0.36 | +15.9% |
| Dec 2025 | 0.54 | 0.44 | -17.8% |
| Sep 2025 | 0.60 | 0.69 | +15.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.52 | 11 | $2.91B | +2.6% |
| Next quarter | 0.61 | 11 | $3.05B | +2.4% |
| Current year | 2.05 | 13 | $11.62B | +3.3% |
| Next year | 2.04 | 13 | $11.87B | +2.1% |
Analyst targets & ownership
Mean target$28.64
High target$40.00
Low target$23.00
Implied upside17.89%
Analyst count11
ConsensusHOLD
Strong buy / Buy0 / 2
Hold11
Sell / Strong sell0 / 0
Held by insiders0.34%
Held by institutions110.22%
Institutions holding951
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
23.70
+2.48% from price
SMA 20
23.65
+3.02% from price
SMA 50
25.31
-3.75% from price
SMA 100
22.97
+5.76% from price
SMA 200
20.88
+16.66% from price
EMA 12
23.84
+1.89% from price
EMA 26
24.11
+0.73% from price
EMA 50
24.11
+0.74% from price
RSI (14)
52.9
Neutral
MACD (12,26,9)
-0.27
Hist 0.15
ATR (14)
0.65
2.69% of price
Realised vol 30D
23.9%
Annualised
Bollinger upper
24.51
20, 2σ
Bollinger lower
22.78
20, 2σ
50 / 200 cross
Golden
25.31 vs 20.88
Trend bias
Above 200
+16.66%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.11
More volatile than market
Correlation to SPY
0.34
Loosely linked
Realised vol 30D
23.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.8%
Peak to trough
Max drawdown 5Y
-82.3%
Peak to trough
ATR 14
0.65
2.69% of price
Beta (reported)
0.65
5Y monthly, from filing
Short interest
Shares short
23.23M
Prior 23.91M
Change vs prior
-2.9%
Shorts covering
% of float
7.09%
Normal
% of shares out
4.49%
Against total outstanding
Days to cover
4.7
Liquid
Float
514.41M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 31, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 31, 26 | Stifel | MAINTAINED | Hold | Hold |
| Jul 31, 26 | Citigroup | UPGRADE | Sell | Neutral |
| Jul 28, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 28, 26 | Stifel | MAINTAINED | Hold | Hold |
| Jul 27, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Jul 15, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 28, 26 | Citigroup | DOWNGRADE | Neutral | Sell |
| May 4, 26 | Barclays | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$0.04 / yr
Forward yield0.16%
5-year avg yield1.72%
Payout ratio154.67%
Ex-dividend dateAug 28, 2026
Next pay dateOct 1, 2026
Last split1841:1000
Split dateJul 1, 2015
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-19
Corporate Changes & Voting Matters
8-K · 2026-08-18
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-07-14
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-08
Periodic Financial Reports
10-Q · 2026-04-30
Headlines
Are Investors Undervaluing Baxter International (BAX) Right Now?
Zacks · 16h ago
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
Zacks · 16h ago
Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
GlobeNewswire · 2d ago
Citigroup Trims Price Target on Baxter International to $27 From $28, Keeps Neutral Rating
MT Newswires · 2d ago
3 of Wall Street’s Favorite Stocks with Warning Signs
StockStory · 6d ago
What Investors Might Be Missing On Baxter International (BAX)
Simply Wall St. · 6d ago
Baxter Releases Inaugural Connected Hospital Report
Business Wire · 7d ago
Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players
GlobeNewswire · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.